|
Patient-reported gastrointestinal outcomes in patients with anal cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Augmenix |
Speakers' Bureau - Oncology Information Group |
Research Funding - Elekta; GE Healthcare; Philips Healthcare |
Patents, Royalties, Other Intellectual Property - Provisional patent on 3D printed oral stents for radiation treatments of head and neck cancer; Royalties from Taylor and Francis LLC for my co-authored book: An introduction to physical oncology |
|
|
Consulting or Advisory Role - Adlai Nortye |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Accuray |
Patents, Royalties, Other Intellectual Property - Oral amifostine for radio protection of the intestinal tract; PHD inhibitors for radio protection of the GI Tract |